The beat-and-raise quarter with margin expansion and a $1.0B buyback authorization is a strong bullish signal. Traders should watch for continued execution on organic growth (4.2% organic revenue growth) and further margin expansion as the company benefits from operating leverage and its LaunchPad cost initiatives.
Price Chart
Executive Summary
Labcorp reported Q2 2026 revenue of $3.73B (up 5.8% YoY) and adjusted EPS of $4.99, beating consensus of $4.77 by 4.6%. The company raised full-year 2026 adjusted EPS guidance to $18.10-$18.55 (up $0.30 at midpoint) and increased its share repurchase authorization by $1.0B to $1.4B. Strong operating margin expansion (adjusted operating margin +70bps to 15.8%) and double-digit adjusted EPS growth (+14.9% YoY) drove the beat, with both Diagnostics and Biopharma segments contributing to the upside.
Key Financial Metrics
Key Facts
- Q2 2026 revenue $3.73B vs $3.53B YoY, up 5.8%
- Adjusted EPS $4.99 vs consensus $4.77, a 4.6% beat
- Raised full-year 2026 adjusted EPS guidance to $18.10-$18.55 (up $0.30 at midpoint)
- Raised full-year revenue growth guidance to 5.4%-6.3% (up 30bps at midpoint)
- Adjusted operating margin expanded 70bps to 15.8%
- Board approved $1.0B increase in share repurchase authorization, bringing total to $1.4B
- Repurchased $353.8M of stock and paid down $500M in senior notes during Q2
- Diagnostics segment revenue +5.5% YoY, Biopharma segment revenue +6.5% YoY
Financial Impact
Q2 revenue $3.73B, adjusted EPS $4.99, raised FY guidance midpoint by $0.30 to $18.10-$18.55
Risk Factors
- Execution risk on integrating recent acquisitions ($225.7M in Q2)
- Potential impact from foreign exchange headwinds (0.4% on enterprise revenue guidance)
- Competitive pressures in the laboratory services market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000920148-26-000162 |
| Document: lh-20260730.htm | 0000920148-26-000162 |
| Document: 0000920148-26-000162-index-headers.html | 0000920148-26-000162 |
| Document: 0000920148-26-000162-index.html | 0000920148-26-000162 |
| Document: 0000920148-26-000162.txt | 0000920148-26-000162 |
| 8-K Data (Synthetic) | 0000920148-26-000162 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 21d ago | 8-K | $311.54 $320.71 | ▲ +2.94% | ▲ +3.16% | $306.35 (−1.67%) |
Aug 28, 2026 5w ago | 8-K | $335.11 $326.89 | ▼ −2.45% | ▼ −2.56% | $306.35 (−8.58%) |
Aug 18, 2026 6w ago | Insider Cluster | $322.18 $337.68 | ▲ +4.81% | ▲ +5.01% | $306.35 (−4.91%) |
Aug 17, 2026 6w ago | 8-K | $323.34 $339.34 | ▲ +4.95% | ▲ +6.14% | $306.35 (−5.26%) |
Aug 14, 2026 7w ago | 8-K | $318.13 $336.34 | ▲ +5.72% | ▲ +7.09% | $306.35 (−3.70%) |
Aug 12, 2026 7w ago | Insider Cluster | $323.48 $330.44 | ▲ +2.15% | ▲ +2.60% | $306.35 (−5.30%) |
Aug 6, 2026 8w ago | Insider Cluster | $316.53 $322.59 | ▲ +1.91% | ▲ +0.70% | $306.35 (−3.22%) |
Jul 30, 2026 9w ago | 8-K | $315.53 $316.53 | ▲ +0.32% | ▼ −3.31% | $306.35 (−2.91%) |
Jul 10, 2026 12w ago | 8-K | $276.81 $281.94 | ▲ +1.85% | ▲ +2.41% | $306.35 (+10.67%) |
Jun 30, 2026 13w ago | 8-K | $283.88 $283.86 | ▼ −0.01% | ▼ −0.27% | $306.35 (+7.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access